Prosecution Insights
Last updated: October 27, 2026

Nyrobi I Celestine, USPTO Patent Examiner

Listed by the USPTO as CELESTINE, NYROBI I

Tech Center 3700 • Art Units: 3771 3793 3796 3798

This examiner grants 81% of resolved cases

Analysis

CELESTINE, NYROBI I is assigned to tech center 3700 and art unit 3771. The record contains 263 resolved cases, an 81.4% allowance rate, and a 957-day median to allowance. The 23.1% interview lift indicates that interviews have been associated with better allowance outcomes in the recorded cases.

The principal companies are GE Precision Healthcare LLC, Fujifilm Corporation, and Canon Inc. The leading firms are OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P., Andrus Intellectual Property Law, LLP, and Boston & Galway. The profile supports a proactive approach that uses examiner communication to refine technical distinctions while maintaining disciplined written prosecution and attention to timing.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

81.4%
Allow Rate
+11.4% vs TC avg
365
Total Applications
+23.1%
Interview Lift
957
Avg Prosecution Days
Based on 263 resolved cases, 2023–2026

Rejection Statute Breakdown

3.2%
§101 Eligibility
19.8%
§102 Novelty
47.0%
§103 Obviousness
26.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19047630 IMAGE PROCESSING DEVICE, ENDOSCOPE SYSTEM, IMAGE PROCESSING METHOD, AND PROGRAM Final Rejection FUJIFILM CORPORATION
19042977 ULTRASOUND DIAGNOSTIC APPARATUS AND METHOD OF CONTROLLING ULTRASOUND DIAGNOSTIC APPARATUS Final Rejection FUJIFILM Corporation
18765333 ULTRASOUND DIAGNOSTIC APPARATUS AND MODEL OPERATION VERIFICATION METHOD Final Rejection FUJIFILM Corporation
18181352 ULTRASOUND DIAGNOSTIC SYSTEM AND METHOD FOR CONTROLLING ULTRASOUND DIAGNOSTIC SYSTEM Final Rejection FUJIFILM Corporation
18667580 METHOD AND APPARATUS FOR DETERMINING USER ANTHROPOLOGICAL TYPE TO REFINE ESTIMATION OF USER'S PHYSIOLOGICAL PARAMETERS Final Rejection Samsung Electronics Co., Ltd.
19278961 ULTRASONIC DIAGNOSTIC APPARATUS, METHOD OF SIGNAL PROCESSING, AND NON-TRANSITORY COMPUTER READABLE MEDIUM Final Rejection Canon Kabushiki Kaisha
18827132 ULTRASONIC DIAGNOSTIC APPARATUS Final Rejection Canon Kabushiki Kaisha
18610342 ULTRASONIC DIAGNOSTIC APPARATUS TO CORRECT TRANSMISSION VOLTAGE TO MAKE DEPTH OF FIELD OF SCAN LINES UNIFORM Non-Final OA CANON KABUSHIKI KAISHA
19236768 REJECTING SPURIOUS MAGNETIC FIELDS DURING MAGNETIC MARKER LOCALIZATION Final Rejection Stryker Corporation
19061593 Portable Ultrasound Systems and Methods Final Rejection Bard Access Systems, Inc.
19045704 MULTI-LUMEN DEVICE FOR ULTRASOUND IMAGING Final Rejection Boston Scientific Scimed, Inc.
19011884 INTRAVASCULAR IMAGING CATHETER Non-Final OA Boston Scientific Scimed, Inc.
18955308 MEDICAL DEVICE GUIDANCE SYSTEM Final Rejection Boston Scientific Scimed, Inc.
19270064 SYSTEMS AND METHODS FOR AUTOMATICALLY GENERATING AN ANATOMICAL BOUNDARY Non-Final OA INTUITIVE SURGICAL OPERATIONS, INC.
19094717 IMAGE DIAGNOSTIC SYSTEM AND METHOD Final Rejection TERUMO KABUSHIKI KAISHA
18082996 Robotic Systems, Methods And Software Programs For Modifying Tool Operation Based On Tissue Parameters Final Rejection MAKO Surgical Corp.
19104458 OPTICAL LENS, PHOTOPLETHYSMOGRAPH, AND ELECTRONIC DEVICE Non-Final OA Honor Device Co., Ltd.
18893919 RADIOTHERAPY TREATMENT TABLE AND SYSTEMS AND METHODS USING THE SAME Non-Final OA SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
19247954 TRANSMISSION AND RECEPTION DEVICE, ULTRASONIC PROBE, AND ULTRASONIC DIAGNOSTIC APPARATUS Final Rejection KONICA MINOLTA, INC.
18925919 METHOD OF THREE-MODE PATIENT CHAIR EXIT SENSING Non-Final OA Hill-Rom Services, Inc.
19278472 Non-Invasive Focused Ultrasound Neuromodulation to Treat Physiological Conditions Final Rejection GE Precision Healthcare LLC
19043584 ELECTROMAGNETIC (EM) MEDICAL DEVICE INSTRUMENT TRACKING APPARATUS Non-Final OA GE Precision Healthcare LLC
18677188 MATERNAL MONITORING SYSTEMS AND METHODS Non-Final OA GE Precision Healthcare LLC
18644742 MATERNAL AND FETAL MONITORING SYSTEMS AND METHODS Final Rejection GE Precision Healthcare LLC
19043622 LIVE ANATOMICAL MAPPING OF THE LEFT ATRIUM WITH ROBOT-ASSISTED INTRA-CARDIAC ECHOCARDIOGRAPH Non-Final OA Siemens Medical Solutions USA, Inc.
18856679 MATERIALS AND METHODS FOR LUMINESCENCE-BASED CARBON DIOXIDE SENSING Non-Final OA The General Hospital Corporation
18711311 PATELLA TRACKING Final Rejection Smith & Nephew Orthopaedics AG
18638104 MACHINE LEARNING METHODS AND SYSTEMS TO DETECT INTERNAL MARKERS USING ULTRASOUND IMAGING Non-Final OA The Texas A&M University System
18226698 SYSTEM AND METHOD FOR EXTRACTION OF JOINT-SPECIFIC MOVEMENT CAPACITY AND MOTION SIGNATURE FROM IMAGING Final Rejection The Cleveland Clinic Foundation
19303778 AUTOMATIC CONTROL AND ENHANCEMENT OF 4D ULTRASOUND IMAGES Non-Final OA Biosense Webster (Israel) Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Nyrobi I Celestine's allowance rate?

81.4% of resolved applications examined by Nyrobi I Celestine were allowed (263 resolved cases), compared with 65.9% across Art Unit 3771 over the last five years.

Does an interview help with examiner Nyrobi I Celestine?

This examiner's interview lift is +23.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Nyrobi I Celestine take to allow a patent?

Applications allowed by Nyrobi I Celestine took 957 days on average from filing to allowance.

Which art unit does examiner Nyrobi I Celestine work in?

Nyrobi I Celestine examines applications in Art Unit 3771 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month